BioSpace News Archive

XACT Robotics™ Ltd. announced today that its XACT ACE™ Robotic System was cleared to market in the U.S. for computed tomography (CT) guided percutaneous procedures.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced ProFound AI™ Risk received a CE Mark in Europe

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film (OTF) showed improved bioavailability of cannabidiol in healthy subjects, compared with 25mg soft gels. Specifically, a pharmacokinetic (PK) study in 14 healthy adults showed a significantly higher serum concentration (Cmax) and significantly faster absorption (Tmax) from CURE’s CBD OTF dose form t

Highlights Genetic Technologies has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in Australia The COVID-19 Severity Risk Test comprises a polygenic risk test (PRS) and assessment for clinical risk factors Genetic Technologies has completed the design and request for initial production of the SNP (Single Nucleotide Polymorphism) panel required to process the polygenic risk test portion of the COVID-19 Severity Risk Test from US-based Thermo Fisher Sc

Technimark, a global manufacturer of custom rigid plastic packaging and components, announced today it has acquired Tool & Plastic Industries Ltd., a leading supplier of injection molded products for the medical device, pharmaceutical and consumer product sectors.

The primary care system in the United States is collapsing due to decades of underinvestment, a poorly designed financing structure and a crushing set of administrative functions.

BioLife Solutions , Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today provided an update on adoption of its evo cold

Congenica , a digital health company enabling rapid analysis of complex genomic data, has launched an update for its clinical decision support platform that will provide automated classification, evidence and reporting of recurrent ‘known’ variants that customers observe in their rare disease cases, significantly saving time wh

CVS Health announced the official launch of Time for Care, a campaign that reinforces the importance of accessing primary health care.

Makes AQC model, designed to improve quality and lower costs, available to smaller practices Also offers immediate support payment to practices that adopt model [15-July-2020] BOSTON , July 15, 2020 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (Blue Cross) is launching an innovative program to improve the quality of patient care, slow the rise o